Back to results
US 12,337,042 B2Granted
Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers
AssigneeUniversity of Iowa Research Foundation
InventorsDongyoul Lee, Michael K. Schultz, Mengshi Li, Nicholas Baumhover, F. Christopher Pigge
Life of this patent
Estimating the term…
Abstract
The present invention provides in certain embodiments a carcinoma-targeting conjugate comprising Formula I: T-L-X wherein T is a SSTR2 targeting ligand, L is a linker, and X is a chelator, for the therapeutic treatment of cancer, and methods of use thereof.
Claims4
A compound having the following structure:
Dependencies are inferred from the claim text.